HydroGraph Clean Power (HG) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
16 Jul, 2026Financial position and production capacity
Over $40 million in cash, zero bank debt, and a lean monthly burn rate of $800,000, providing a multi-year runway for operations.
Cleared to break ground on a large-scale facility with initial capacity of 400 tons per year, expandable to over 750 tons as demand grows.
Modular reactor approach allows for rapid, demand-driven scaling, with each pod of six reactors producing 60 tons annually.
Partnership with Western International secures stable, long-term acetylene feedstock and land for expansion.
Expansion potential includes thousands of tons annually, with international growth possible through Western’s global footprint.
Commercialization and product development
Over 80 customers are actively testing graphene products, with strong inbound interest, especially for the new paste product.
Paste product offers four times the graphene concentration of competitors, a two-year shelf life, and easier integration for industries like concrete and polymers.
Compounding Partners Program ensures quality processing and de-risks customer adoption, focusing on large-scale, high-value opportunities.
Customer qualification timelines are shortening, with several industrial contracts in negotiation and a focus on near-term orders.
Product consistently meets or exceeds customer specs, with nanoscale, ultra-pure, and batch-consistent graphene.
Strategic initiatives and market positioning
U.S. redomicile and Austin headquarters position the company as a leading domestic supplier, aligning with federal priorities for onshore critical materials.
Defense division established to pursue government and defense opportunities.
Actively pursuing U.S. government grants to support domestic graphene supply chain initiatives.
Technical innovations continue, with new CTO scaling capabilities and ongoing R&D in Austin.
Plans for further vertical integration and in-house production of formulated products as capabilities expand.